Whilst a null-mutation of SLC30A7 in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mouse model of PCa accelerated prostate tumour formation (193), the role of SLC30A7 in CRPC has not been extensively studied. This evidence concerns the gene SLC30A7 and adenocarcinoma.